A Phase 1 Study To Evaluate The Effect Of Glasdegib On The Cardiac Repolarization In Healthy Subjects

NCT03162900 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Glasdegib Therapeutic Exposure
DRUG: Glasdegib Supra-therapeutic Exposure
DRUG: Positive Control (Moxifloxacin)
OTHER: Placebo Control

Sponsor

Pfizer